✦ LIBER ✦

Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide

✍ Scribed by Johansson, Harriet; Bonanni, Bernardo; Gandini, Sara; Guerrieri-Gonzaga, Aliana; Cazzaniga, Massimiliano; Serrano, Davide; Macis, Debora; Puccio, Antonella; Sandri, Maria Teresa; Gulisano, Marcella; Formelli, Franca; DeCensi, Andrea

Book ID: 121404962
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 390 KB
Volume: 142
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-013-2768-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P41 A randomized 2 × 2 biomarker trial o

P41 A randomized 2 × 2 biomarker trial of low-dose tamoxifen and fenretinide in premenopausal women at-high risk for breast cancer

✍ S. Mora; C. Robertson; A. Guenieri-Gonzaga; M. Cazzaniga; H. Johansson; D. Serra 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Circulating Sex Steroids and Breast Canc

Circulating Sex Steroids and Breast Cancer Risk in Premenopausal Women

✍ Susan E. Hankinson; A. Heather Eliassen 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 177 KB

A randomized phase II presurgical trial

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

✍ Serrano, Davide; Lazzeroni, Matteo; Gandini, Sara; Macis, Debora; Johansson, Har 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 233 KB

Tamoxifen reduces the risk of contralate

Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial

✍ Sara Alkner; Pär-Ola Bendahl; Mårten Fernö; Bo Nordenskjöld; Lisa Rydén 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Tamoxifen reduces the risk of contralate

Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial

✍ Day, S.F.; Bevers, T.B. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 66 KB

P1 Circulating adiponectin levels as a p

P1 Circulating adiponectin levels as a predictive factor of breast cancer in a double-blind 2×2 phase II trial of low-dose tamoxifen and fenretinide for breast cancer prevention

✍ A. Guerrieri Gonzaga; S. Gandini; H. Johansson; D. Macis; P. Magni; E. Dozio; M. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 154 KB